Original HTML
SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 55,867 shares of GRAIL's common stock to 59 recently hired non-executive employees as an inducement material to their acceptance of employment with GRAIL. The employment inducement awards were granted under GRAIL's Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).
The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over an approximately four year period, with 25% of the award vesting Aug. 31, 2027, and on each one year anniversary of those respective dates thereafter, subject to continued employment with GRAIL (or any successor to or subsidiary of the Company) through the vesting dates.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Sunnyvale, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.
SOURCE GRAIL, Inc.
Share this article
Original Summary
<p>SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of...</p>
Generated Article_json
{"target_audience": "b2b", "is_medical": true, "ai_generated_title": "GRAIL Grants 55,867 RSUs to 59 New Hires as Inducement Awards", "body_html": "<p><strong>Sunnyvale -- [CURRENT_DATE] --</strong> GRAIL, Inc. (Nasdaq: GRAL) has granted restricted stock units covering 55,867 shares of common stock to 59 newly hired non-executive employees as a hiring inducement.</p><h5>GRAIL structures the equity grant under Nasdaq's inducement rule</h5><p>The awards were issued under GRAIL's Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The plan applies exclusively to individuals who were not previously GRAIL employees, or who return after a bona fide period of non-employment, as a material inducement to join the company.</p><h5>Vesting extends over a four-year schedule tied to continued employment</h5><p>The RSUs vest over approximately four years, with 25% vesting on Aug. 31, 2027, and the remainder vesting in equal annual installments on each subsequent anniversary. Vesting remains contingent on the recipients' continued employment with GRAIL or any successor or subsidiary through each vesting date.</p><p>GRAIL is headquartered in Sunnyvale, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom.</p>", "meta_description": "GRAIL grants 55,867 RSUs to 59 new non-executive hires under its Nasdaq-compliant inducement equity plan, vesting over four years starting Aug. 31, 2027.", "seo_keywords": "GRAIL, Nasdaq GRAL, inducement equity plan, restricted stock units, RSU grant, Nasdaq Listing Rule 5635(c)(4), employee compensation, healthcare hiring", "companies": ["GRAIL, Inc."], "industries": ["Biopharmaceuticals"], "markets_regions": ["United States"], "news_type": ["financial_disclosure"], "themes": ["employee_compensation", "corporate_governance"], "products": [], "events": [], "cta_text": "Details on GRAIL's inducement equity plan and workforce expansion are available via the company's official announcement.", "learn_more": "https://grail.com", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
